ATC Group: N05AH03 Olanzapine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N05AH03 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N05 Psycholeptics
3 N05A Antipsychotics
4 N05AH Diazepines, oxazepines and thiazepines
5 N05AH03 Olanzapine

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code Route Amount Notes
ORAL Oral 10 mg
PAREN Parenteral 10 mg
PAREN Parenteral 10 mg (depot)

Active ingredients in N05AH03

Active Ingredient

Olanzapine is an antipsychotic, antimanic and mood stabilising agent that demonstrates a broad pharmacologic profile across a number of receptor systems.

Related product monographs

Document Type Information Source  
 OZAPRAM Film-coated tablet MPI, EU: SmPC Υπουργείο Υγείας (CY)
 ZYPREXA Coated tablet MPI, EU: SmPC European Medicines Agency (EU)
 ZYPREXA Powder for solution for injection MPI, EU: SmPC European Medicines Agency (EU)
 ZYPREXA Tablet / Tablet, orally disintegrating / Powder for solution for injection MPI, US: SPL/PLR FDA, National Drug Code (US)

Medicines in this ATC group

United States (US)

Albania (AL)

Australia (AU)

Canada (CA)

Finland (FI)

France (FR)

Germany (DE)

Israel (IL)

Japan (JP)

Mexico (MX)

Netherlands (NL)

New Zealand (NZ)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.